Humanetics Licenses Patents
MINNEAPOLIS--Humanetics Corp. licensed pharmaceutical rights to its patents on 150 compounds to Hollis-Eden Pharmaceuticals Inc., which will evaluate the compounds for possible use in pharmaceutical products. Humanetics' 7-Keto is among the licensed compounds.
"It won't affect anybody in the supplement industry [adversely]. If anything, it may help," said Humanetics president Ronald Zenk. "We're going to continue to sell 7-Keto as a dietary supplement, and Hollis-Eden will evaluate 7-Keto amongst the other 149 compounds and compare it and choose which compounds they'd like to use in pharmaceutical development."
